0.5% bupivacaine HCL
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for 0.5% bupivacaine HCL, covering 2022-02-01 to 2022-02-01. Get the full timeline:
Most recent: Clinical Trial Update: Liposomal Bupivacaine (Exparel ® ) Plus 0.5% Bupivacaine HCL Versus 0.5% Bupivacaine HCL for Interscalene Nerve Block (ISB) for Patients Undergoing Total Shoulder Arthroplasty(TSA) [Phase 4]